Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 39

1.

Towards combination HIV prevention for injection drug users: addressing addictophobia, apathy and inattention.

Strathdee SA, Shoptaw S, Dyer TP, Quan VM, Aramrattana A; Substance Use Scientific Committee of the HIV Prevention Trials Network.

Curr Opin HIV AIDS. 2012 Jul;7(4):320-5. doi: 10.1097/COH.0b013e32835369ad. Review.

PMID:
22498479
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage.

Mathers BM, Degenhardt L, Ali H, Wiessing L, Hickman M, Mattick RP, Myers B, Ambekar A, Strathdee SA; 2009 Reference Group to the UN on HIV and Injecting Drug Use.

Lancet. 2010 Mar 20;375(9719):1014-28. doi: 10.1016/S0140-6736(10)60232-2. Epub 2010 Feb 26. Review.

PMID:
20189638
[PubMed - indexed for MEDLINE]
3.

Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.

Birkhead GS, Klein SJ, Candelas AR, O'Connell DA, Rothman JR, Feldman IS, Tsui DS, Cotroneo RA, Flanigan CA.

Int J Drug Policy. 2007 Oct;18(5):417-25. Epub 2007 Feb 20. Review.

PMID:
17854731
[PubMed - indexed for MEDLINE]
4.

Dual HIV risk and vulnerabilities among women who use or inject drugs: no single prevention strategy is the answer.

El-Bassel N, Wechsberg WM, Shaw SA.

Curr Opin HIV AIDS. 2012 Jul;7(4):326-31. doi: 10.1097/COH.0b013e3283536ab2. Review.

PMID:
22498480
[PubMed - indexed for MEDLINE]
5.

Prevention of HIV infection among injection drug users in resource-limited settings.

Vlahov D, Robertson AM, Strathdee SA.

Clin Infect Dis. 2010 May 15;50 Suppl 3:S114-21. doi: 10.1086/651482. Review.

PMID:
20397939
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Hepatitis C and HIV infections: implications for clinical care in injection drug users.

Sullivan LE, Fiellin DA.

Am J Addict. 2004 Jan-Feb;13(1):1-20. Review.

PMID:
14766434
[PubMed - indexed for MEDLINE]
7.

[Intravenous drug use and the spread of HIV; an international perspective].

Meijerink H, van Crevel R, van der Ven AJ.

Ned Tijdschr Geneeskd. 2013;157(21):A5690. Review. Dutch.

PMID:
23693006
[PubMed - indexed for MEDLINE]
8.

Treatment and care for injecting drug users with HIV infection: a review of barriers and ways forward.

Wolfe D, Carrieri MP, Shepard D.

Lancet. 2010 Jul 31;376(9738):355-66. doi: 10.1016/S0140-6736(10)60832-X. Review.

PMID:
20650513
[PubMed - indexed for MEDLINE]
9.

Adherence to HIV treatment among IDUs and the role of opioid substitution treatment (OST).

Spire B, Lucas GM, Carrieri MP.

Int J Drug Policy. 2007 Aug;18(4):262-70. Epub 2007 Jan 26. Review.

PMID:
17689374
[PubMed - indexed for MEDLINE]
10.

Syringe availability as HIV prevention: a review of modalities.

Coffin P.

J Urban Health. 2000 Sep;77(3):306-30. Review.

PMID:
10976607
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Key harm reduction interventions and their impact on the reduction of risky behavior and HIV incidence among people who inject drugs in low-income and middle-income countries.

Dutta A, Wirtz AL, Baral S, Beyrer C, Cleghorn FR.

Curr Opin HIV AIDS. 2012 Jul;7(4):362-8. doi: 10.1097/COH.0b013e328354a0b5. Review.

PMID:
22647588
[PubMed - indexed for MEDLINE]
12.

[Illegal drug users and risk factors for HIV and HCV infection].

Backmund M.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2007 Apr;50(4):471-5. Review. German.

PMID:
17377722
[PubMed - indexed for MEDLINE]
13.

HIV prevention among injection drug users: the need for integrated models.

Metzger DS, Navaline H.

J Urban Health. 2003 Dec;80(4 Suppl 3):iii59-66. Review.

PMID:
14713672
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Syringe exchange: HIV prevention, key findings, and future directions.

Paone D, Des Jarlais DC, Gangloff R, Milliken J, Friedman SR.

Int J Addict. 1995;30(12):1647-83. Review.

PMID:
8557411
[PubMed - indexed for MEDLINE]
15.

Evidence for the effectiveness of sterile injecting equipment provision in preventing hepatitis C and human immunodeficiency virus transmission among injecting drug users: a review of reviews.

Palmateer N, Kimber J, Hickman M, Hutchinson S, Rhodes T, Goldberg D.

Addiction. 2010 May;105(5):844-59. doi: 10.1111/j.1360-0443.2009.02888.x. Epub 2010 Mar 2. Review.

PMID:
20219055
[PubMed - indexed for MEDLINE]
16.

HIV/hepatitis C virus co-infection in drug users: risk behavior and prevention.

Hagan H, Thiede H, Des Jarlais DC.

AIDS. 2005 Oct;19 Suppl 3:S199-207. Review.

PMID:
16251818
[PubMed - indexed for MEDLINE]
17.

Optimal provision of needle and syringe programmes for injecting drug users: A systematic review.

Jones L, Pickering L, Sumnall H, McVeigh J, Bellis MA.

Int J Drug Policy. 2010 Sep;21(5):335-42. doi: 10.1016/j.drugpo.2010.02.001. Epub 2010 Feb 26. Review.

PMID:
20189375
[PubMed - indexed for MEDLINE]
18.

Epidemiology of HIV/AIDS, hepatitis B, hepatitis C, and tuberculosis among minority injection drug users.

Estrada AL.

Public Health Rep. 2002;117 Suppl 1:S126-34. Review.

PMID:
12435836
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

The role of needle exchange programs in HIV prevention.

Vlahov D, Junge B.

Public Health Rep. 1998 Jun;113 Suppl 1:75-80. Review.

PMID:
9722812
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Strategies to improve access to sterile syringes for injection drug users.

Rich JD, Wolf FA, Macalino G.

AIDS Read. 2002 Dec;12(12):527-35. Review.

PMID:
12518719
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk